Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation
Abstract The prevalence and dire implications of mutations in the tumour suppressor, p53, highlight its appeal as a chemotherapeutic target. We recently showed that impairing cellular antioxidant systems via inhibition of SLC7A11, a component of the system xc − cystine-glutamate antiporter, enhances...
Guardado en:
Autores principales: | Julia V. Milne, Bonnie Z. Zhang, Kenji M. Fujihara, Swati Dawar, Wayne A. Phillips, Nicholas J. Clemons |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ba9b4fb88cd4428c8a2cf11039b060f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246
por: Lena Haffo, et al.
Publicado: (2018) -
A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
por: Liang Y, et al.
Publicado: (2018) -
A δ38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity.
por: Stefan Schneider, et al.
Publicado: (2012) -
Erythrocyte transketolase activity, markers of cardiac dysfunction and the diagnosis of infantile beriberi.
por: Douangdao Soukaloun, et al.
Publicado: (2011) -
APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude mice
por: Liang Y, et al.
Publicado: (2019)